160 related articles for article (PubMed ID: 19415250)
1. Long-term retention rate of pramipexole in the treatment of Parkinson's disease.
Keränen T; Tuhkasaari M; Kuusisto H
Eur J Clin Pharmacol; 2009 Sep; 65(9):955-6; author reply 957. PubMed ID: 19415250
[No Abstract] [Full Text] [Related]
2. Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
Bares M; Rektorová I; Krajcovicová L; Rektor I
J Neurol; 2008 Oct; 255(10):1596; author reply 1597. PubMed ID: 18758889
[No Abstract] [Full Text] [Related]
3. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
Lyons KE; Pahwa R
Mov Disord; 2009 Oct; 24(14):2121-7. PubMed ID: 19768728
[TBL] [Abstract][Full Text] [Related]
4. Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.
Perez Lloret S; Rascol O
Expert Opin Pharmacother; 2010 Sep; 11(13):2221-30. PubMed ID: 20670197
[TBL] [Abstract][Full Text] [Related]
5. Pramipexole-induced obsessive-compulsive symptoms in a patient with Parkinson's disease and disgust sensitivity.
Gopalan P; Azzam PN; Hudak R
Psychosomatics; 2013; 54(3):286-9. PubMed ID: 23218062
[No Abstract] [Full Text] [Related]
6. Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.
Kulisevsky J; Pagonabarraga J; Martinez-Corral M
J Neurol; 2009 May; 256(5):816-9. PubMed ID: 19240966
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Utsumi H; Okuma Y; Kano O; Suzuki Y; Iijima M; Tomimitsu H; Hashida H; Kubo S; Suzuki M; Nanri K; Matsumura M; Murakami H; Hattori N;
Intern Med; 2013; 52(3):325-32. PubMed ID: 23370739
[TBL] [Abstract][Full Text] [Related]
8. Auditory musical hallucinations associated with extended-release pramipexole in an elderly patient with Parkinson's disease.
Kataoka H; Ueno S
Medicine (Baltimore); 2014 Dec; 93(27):e251. PubMed ID: 25501095
[TBL] [Abstract][Full Text] [Related]
9. A case of severe leg oedema in a patient with Parkinson's disease treated with pramipexole.
Cicero CE; Nicoletti A; Mostile G; Zappia M
Postgrad Med J; 2016 Aug; 92(1090):484. PubMed ID: 26941267
[No Abstract] [Full Text] [Related]
10. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.
Driver-Dunckley E; Samanta J; Stacy M
Neurology; 2003 Aug; 61(3):422-3. PubMed ID: 12913220
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group.
JAMA; 1997 Jul; 278(2):125-30. PubMed ID: 9214527
[TBL] [Abstract][Full Text] [Related]
12. Dopamine dysregulation syndrome in Parkinson's disease patients with unsatisfactory switching from immediate to extended release pramipexole: a further clue to incentive sensitization mechanisms?
Solla P; Cannas A; Corona M; Marrosu MG; Marrosu F
Behav Neurol; 2013 Jan; 27(4):563-6. PubMed ID: 23242362
[TBL] [Abstract][Full Text] [Related]
13. [Severe leg edema associated with the use of dopaminergic drugs in Parkinson's disease. Report of one case].
Miranda C M; Hudson A L
Rev Med Chil; 2017 Dec; 145(12):1624-1625. PubMed ID: 29652961
[TBL] [Abstract][Full Text] [Related]
14. Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice.
Abbasi MH; Esmaeili S; Habibi SA; Shahidi GA
J Clin Neurosci; 2020 Sep; 79():219-223. PubMed ID: 33070900
[TBL] [Abstract][Full Text] [Related]
15. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
Bostwick JM; Hecksel KA; Stevens SR; Bower JH; Ahlskog JE
Mayo Clin Proc; 2009 Apr; 84(4):310-6. PubMed ID: 19339647
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
[TBL] [Abstract][Full Text] [Related]
17. Switching from pergolide to pramipexole in patients with Parkinson's disease.
Hanna PA; Ratkos L; Ondo WG; Jankovic J
J Neural Transm (Vienna); 2001; 108(1):63-70. PubMed ID: 11261747
[TBL] [Abstract][Full Text] [Related]
18. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
Bienfait KL; Menza M; Mark MH; Dobkin RD
J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
[TBL] [Abstract][Full Text] [Related]
19. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
Rascol O
Eur J Neurol; 2011 Mar; 18 Suppl 1():3-10. PubMed ID: 21255197
[TBL] [Abstract][Full Text] [Related]
20. Panic attack like episodes possibly associated with pramipexole therapy in Parkinson's disease.
Alonso-Navarro H; Jiménez-Jiménez FJ
Eur J Neurol; 2007 May; 14(5):e1. PubMed ID: 17437590
[No Abstract] [Full Text] [Related]
[Next] [New Search]
